Charles River latest CRO to muscle in on Phase I
Charles River Laboratories is the latest in a series of large contract research organisations making acquisitions to beef up their Phase I capacity as this market sector remains hot.
Archives for November 9, 2006
3M sells pharma biz for $2.1bn
Diversified manufacturer 3M has announced it has agreed to sell its global drug making business for around $2.1bn (€1.6bn) in a three-part deal.
BASF raises prices on intermediates
BASF has announced it is raising it prices globally for some of its intermediate products to offset higher raw material costs.
DSM and UMN sign manufacturing deal
DSM Biologics, the biopharma arm of DSM group, has signed a manufacturing deal with Japanese UMN Pharma based on the firm's novel recombinant protein manufacturing platform.
The Lancet weighs into boiling REACH chemicals debate
One of the most influential medical journals, The Lancet, has weighed into the European REACH chemicals debate, which is at near boiling point as the draft legislation approaches its final approval date in December.